Holland & Barrett Bets on High Street Revival with Public Health Focus
Health foods retailer Holland & Barrett is embarking on a significant strategic shift, reinforcing its high street presence through free health drop-in services. This move comes as the company responds to widespread online misinformation and an increasingly strained National Health Service.
Financial Challenges and Strategic Restructuring
The 155-year-old retailer has faced substantial financial difficulties in recent years. In the fiscal year ending September last year, Holland & Barrett's pre-tax losses expanded from £72 million to £81 million, despite achieving an 11 percent increase in turnover to £719 million. The company, owned by investment firm LetterOne, last recorded a pre-tax profit in September 2021.
Chief Executive Anthony Houghton, who assumed leadership in October, explained that the business has undergone comprehensive restructuring to adapt to contemporary demands. "We've been on quite a big investment program," Houghton told City AM. "It's a 155-year-old business and in many parts of the business it was 155 years [old], and we've brought it into the 21st century."
Addressing Public Health Gaps
Houghton emphasized that many consumers remain unaware of Holland & Barrett's full capabilities. "There's many, many, many people that walk past our store or click past our site every day and they've heard of Holland & Barrett, but they don't really know what we do," he noted.
The retailer's new initiative includes offering 300,000 free in-store wellness consultations with trained staff. This effort aligns with the company's broader ambition to support at least 10 million people annually by 2030 through community programs, charity partnerships, and digital services.
A recent "state of the nation's health" report commissioned by Holland & Barrett revealed that 78 percent of Britons only visit doctors when "absolutely necessary." Houghton attributed this trend to systemic pressures. "You can see that we've got a fabulous NHS system, but it's under pressure and people are more and more confused by advice or can't get access to advice in a language that they understand," he stated.
Capitalizing on Weight-Loss Market Trends
Holland & Barrett is also positioning itself to benefit from the rising popularity of weight-loss medications, particularly GLP-1 agonists like Wegovy. Research from University College London indicates that approximately 1.6 million UK adults used weight-loss drugs in the past year, with Wegovy soon to be available through the NHS.
The retailer plans to introduce a specialized product range tailored for users of these medications. Houghton explained, "Rather than a customer getting the drug and not fully understanding the impact of the drug on their weight, it's [about] where they can go and get that advice and therefore get the supplements to support that weight loss, which is really, really important."
Future Outlook and Historical Context
Founded in 1870, Holland & Barrett operates over 800 stores across the United Kingdom. The company's renewed emphasis on preventative care and high street accessibility reflects a post-pandemic shift in consumer behavior. Houghton observed, "One of the things that we noticed post-Covid is more and more people are getting focused on preventative care."
This strategic pivot aims to attract consumers who may not regularly engage with the NHS or prioritize their health, positioning Holland & Barrett as a complementary resource in the national healthcare landscape.
